Literature DB >> 34006213

mTOR controls endoplasmic reticulum-Golgi apparatus trafficking of VSVg in specific cell types.

Alicja Koscielny1, Ewa Liszewska1, Katarzyna Machnicka1, Michalina Wezyk1,2, Katarzyna Kotulska3, Jacek Jaworski4.   

Abstract

BACKGROUND: Mammalian/mechanistic target of rapamycin (mTOR) complexes are essential for cell proliferation, growth, differentiation, and survival. mTORC1 hyperactivation occurs in the tuberous sclerosis complex (TSC). mTORC1 localizes to the surface of lysosomes, where Rheb activates it. However, mTOR was also found on the endoplasmic reticulum (ER) and Golgi apparatus (GA). Recent studies showed that the same inputs regulate ER-to-GA cargo transport and mTORC1 (e.g., the level of amino acids or energy status of the cell). Nonetheless, it remains unknown whether mTOR contributes to the regulation of cargo passage through the secretory pathway.
METHODS: The retention using selective hooks (RUSH) approach was used to image movement of model cargo (VSVg) between the ER and GA in various cell lines in which mTOR complexes were inhibited. We also investigated VSVg trafficking in TSC patient fibroblasts.
RESULTS: We found that mTOR inhibition led to the overall enhancement of VSVg transport through the secretory pathway in PC12 cells and primary human fibroblasts. Also, in TSC1-deficient cells, VSVg transport was enhanced.
CONCLUSIONS: Altogether, these data indicate the involvement of mTOR in the regulation of ER-to-GA cargo transport and suggest that impairments in exocytosis may be an additional cellular process that is disturbed in TSC.

Entities:  

Keywords:  Endoplasmic reticulum; Golgi apparatus; MTOR; Retention using selective hooks; Tuberous sclerosis complex; VSVg

Year:  2021        PMID: 34006213     DOI: 10.1186/s11658-021-00262-z

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  46 in total

1.  Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.

Authors:  Alessia Di Nardo; Ioannis Kramvis; Namjik Cho; Abbey Sadowski; Lynsey Meikle; David J Kwiatkowski; Mustafa Sahin
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 2.  Making new contacts: the mTOR network in metabolism and signalling crosstalk.

Authors:  Mitsugu Shimobayashi; Michael N Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

3.  French Society of EEG and Clinical Neurophysiology. Paris, 5 October 1988. Abstracts.

Authors: 
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1989-09

Review 4.  Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.

Authors:  Katarzyna Switon; Katarzyna Kotulska; Aleksandra Janusz-Kaminska; Justyna Zmorzynska; Jacek Jaworski
Journal:  IUBMB Life       Date:  2016-10-31       Impact factor: 3.885

Review 5.  Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR).

Authors:  Anna R Malik; Malgorzata Urbanska; Matylda Macias; Agnieszka Skalecka; Jacek Jaworski
Journal:  Biochim Biophys Acta       Date:  2012-12-29

6.  Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway.

Authors:  Xiuyun Jiang; Raymond S Yeung
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

7.  Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Authors:  D D Sarbassov; Siraj M Ali; Do-Hyung Kim; David A Guertin; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

Review 8.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

9.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.

Authors:  Carmine Settembre; Roberto Zoncu; Diego L Medina; Francesco Vetrini; Serkan Erdin; SerpilUckac Erdin; Tuong Huynh; Mathieu Ferron; Gerard Karsenty; Michel C Vellard; Valeria Facchinetti; David M Sabatini; Andrea Ballabio
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598

10.  mTOR activates the VPS34-UVRAG complex to regulate autolysosomal tubulation and cell survival.

Authors:  Michael J Munson; George Fg Allen; Rachel Toth; David G Campbell; John M Lucocq; Ian G Ganley
Journal:  EMBO J       Date:  2015-07-02       Impact factor: 11.598

View more
  1 in total

1.  Molecular pathways enhance drug response prediction using transfer learning from cell lines to tumors and patient-derived xenografts.

Authors:  Yi-Ching Tang; Reid T Powell; Assaf Gottlieb
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.